CSIMarket
 


Pfizer Inc  (PFE)
Other Ticker:  
 
 
 

PFE's vs. Competition, Income Growth by Segments

(Income Q 3 Growth Rates)



COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE All other - -
Biogen Inc BIIB TECFIDERA - -
Biogen Inc BIIB PLEGRIDY - -
Biogen Inc BIIB AVONEX - -
Biogen Inc BIIB TYSABRI - -
Gilead Sciences Inc GILD Letairis - -
Merck and Co Inc MRK Singulair - -
Merck and Co Inc MRK Remicade - -
Amgen Inc AMGN ENBREL - -
APROX. MARKET   SUBTOTAL - -
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Animal Health - -
Eli Lilly And Company LLY Animal health - -
Merck and Co Inc MRK All Other - -
Patterson Companies Inc PDCO Veterinary supply 75.62 % 94.09 %
Petvivo Holdings Inc PETV Total - -
APROX. MARKET   SUBTOTAL 69.46 % 113.32 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Arthritis & pain - -
Bristol myers Squibb Company BMY Other - -
Johnson and Johnson JNJ REMICADE - -
Biogen Inc BIIB PLEGRIDY - -
Biogen Inc BIIB TECFIDERA - -
Amgen Inc AMGN Other product sales - -
Amgen Inc AMGN EPOGEN TM - -
Bristol myers Squibb Company BMY ORENCIA - -
Amgen Inc AMGN ENBREL - -
Abbvie inc ABBV HUMIRA - -
Abbott Laboratories ABT Established Pharmaceutical Products 10.63 % 2.91 %
APROX. MARKET   SUBTOTAL 10.63 % 2.91 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Cardiovascular & metabolic diseases - -
Gilead Sciences Inc GILD Ranexa - -
Abbott Laboratories ABT Other - -
Amgen Inc AMGN Other product sales - -
Eli Lilly And Company LLY Cardiovascular - -
Mylan N v MYL Total -13.41 % 155.27 %
Merck and Co Inc MRK CozaarHyzaar - -
Merck and Co Inc MRK Zocor - -
Merck and Co Inc MRK Zetia - -
Merck and Co Inc MRK Januvia - -
Enact Holdings Inc ACT Generic pharmaceutical products -96.06 % -97.36 %
Abbvie inc ABBV Other - -
Bristol myers Squibb Company BMY Eliquis - -
APROX. MARKET   SUBTOTAL -53.77 % -48.73 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Central nervous system disorders - -
Bristol myers Squibb Company BMY ABILIFY - -
Eli Lilly And Company LLY Neurosciences - -
Johnson and Johnson JNJ RISPERDAL - -
Merck and Co Inc MRK Other - -
Mylan N v MYL Total -13.41 % 155.27 %
Merck and Co Inc MRK Zocor - -
Enact Holdings Inc ACT Generic pharmaceutical products -96.06 % -97.36 %
Johnson and Johnson JNJ INVEGA - -
APROX. MARKET   SUBTOTAL -53.77 % -48.73 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Consumer Healthcare and Vaccines - -
Bristol myers Squibb Company BMY Nutritionals - -
Johnson and Johnson JNJ Nutritionals - -
Procter and Gamble Co PG Health Care -2.4 % 69.06 %
Allergan plc AGN Skin Care - -
Enact Holdings Inc ACT Dermatology and Established Brands - -
Allergan plc AGN Eye Care Pharmaceuticals - -
Johnson and Johnson JNJ Skin Care - -
Merck and Co Inc MRK Vaccines - -
HOSPIRA, INC. HSP Injectable Pharmaceutical - -
Baxter International Inc BAX Vaccines - -
Zivo Bioscience Inc ZIVO Total - -
Balchem Corp BCPC Total -7.92 % -6.3 %
APROX. MARKET   SUBTOTAL -73 % -76.46 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Endocrine disorders - -
Eli Lilly And Company LLY Endocrinology - -
Merck and Co Inc MRK Januvia - -
APROX. MARKET   SUBTOTAL - -
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Infectious & respiratory diseases - -
Merck and Co Inc MRK Singulair - -
APROX. MARKET   SUBTOTAL - -
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Oncology - -
Bristol myers Squibb Company BMY Other - -
Eli Lilly And Company LLY Oncology - -
Johnson and Johnson JNJ PROCRIT - -
Amgen Inc AMGN EPOGEN TM - -
Amgen Inc AMGN Vectibix - -
Amgen Inc AMGN Sensipar TM - -
Celgene Corp CELG ABRAXANE - -
Enact Holdings Inc ACT Branded pharmaceutical products 1484.4 % -68.05 %
Johnson and Johnson JNJ VELCADE - -
APROX. MARKET   SUBTOTAL 1484.4 % -68.05 %
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Ophthalmology - -
Allergan plc AGN Eye Care Pharmaceuticals - -
APROX. MARKET   SUBTOTAL - -
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Total - -
APROX. MARKET   SUBTOTAL - -
COMPANY NAME TICKER SEGMENT NAME Inc. Y / Y Inc. SEQ.
Pfizer Inc PFE Urology - -
Johnson and Johnson JNJ Other - -
Mylan N v MYL Total -13.41 % 155.27 %
Enact Holdings Inc ACT Branded pharmaceutical products 1484.4 % -68.05 %
Enact Holdings Inc ACT Urology and Gastroenterology - -
APROX. MARKET   SUBTOTAL 79.4 % -47.1 %





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com